Ignite Creation Date:
2024-05-05 @ 11:42 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00112905
Status:
TERMINATED
Last Update Posted:
2014-05-30
First Post:
2005-06-02
Brief Title:
Sorafenib in Treating Patients With Regional or Metastatic Cancer of the Urothelium
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Adenocarcinoma of the Bladder |
| Distal Urethral Cancer |
| Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter |
| Proximal Urethral Cancer |
| Recurrent Bladder Cancer |
| Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter |
| Recurrent Urethral Cancer |
| Regional Transitional Cell Cancer of the Renal Pelvis and Ureter |
| Squamous Cell Carcinoma of the Bladder |
| Stage III Bladder Cancer |
| Stage IV Bladder Cancer |
| Transitional Cell Carcinoma of the Bladder |
| Urethral Cancer Associated With Invasive Bladder Cancer |
Keywords: